.
Hands FAO logo

ELECTRONIC FORUM ON BIOTECHNOLOGY IN
FOOD AND AGRICULTURE: SUMMARY CONFERENCE 6

.
The Forum | Join Forum | Forum News | Contact Forum


 Forum home

 Conference 6
  Background
  Archives
  Summary

 Conference 1
 Conference 2
 Conference 3
 Conference 4
 Conference 5
 Conference 7
 Conference 8
 Conference 9
 Conference 10
 Conference 11  Conference 12
 Conference 13
 Conference 14
 Conference 15
 Conference 16

     

    SUMMARY CONFERENCE 6

    Conference 6 of the FAO Electronic Forum on Biotechnology in Food and Agriculture was entitled "The impact of intellectual property rights (IPRs) on food and agriculture in developing countries". It ran from 20 March to 14 May 2001.

    The Summary Document provides a summary of the main arguments and concerns discussed during the conference, including:
    - Companies from developed countries patenting genetic material from developing countries
    - Impact on agricultural research
    - Whether IPRs favour the interests of developed countries and the biotechnology industry over those of developing countries
    - Avoiding or alleviating the negative impacts of the current IPRs system
    - National IPRs legislation in developing countries

    Read the Long Summary Document of this conference.

    Read the Short Summary Document of this conference [below].


    I. Summary Document (Short Version) - Conference 6

    The sixth conference of the FAO Electronic Forum on Biotechnology in Food and Agriculture was entitled "The impact of intellectual property rights (IPRs) on food and agriculture in developing countries" and it ran from 20 March to 14 May 2001. A total of 265 Forum members registered and 50 messages were posted during the 8-week long conference. Roughly two thirds came from participants in developed countries and one third from developing countries and they were posted by 30 individuals from diverse walks of life (e.g. research institutes, NGOs, private industry, patent lawyers) in 18 different countries.

    Throughout the conference, the crop sector received far more attention than the other agricultural sectors while the kinds of IPRs specifically discussed were patents and, to a lesser degree, plant variety protection (PVP). In addition, genetic modification was the biotechnology that participants singled out for particular attention.

    The messages covered a wide range of subject areas. In general, most participants seemed to consider the impacts of IPRs to be primarily negative for the developing world. Their comments on the impacts or consequences of IPRs can be grouped into three major themes:

    1. The patenting of genetic material from developing countries by companies from developed countries:

    From the messages posted, this seems to be one of the most controversial consequences of the current IPRs system and some participants expressed strong frustration and anger about this situation. These strong reactions stemmed from the perceived
    a) appropriation of the resources in developing countries by parties in developed countries (cases, such as the recent granting of a patent involving the Nuna bean, were discussed)
    b) lack of adequate mechanisms to prevent it happening
    c) failure to acknowledge the contribution made by farmers in developing countries to the genetic resources
    d) failure to share the benefits with farmers in developing countries

    Other topics discussed here were the definition of what is patentable, the difference between discovery and invention and the potential role of relevant international agreements (such as the Convention on Biological Diversity).

    2. The impact on agricultural research

    Participants suggested that IPRs had influenced (generally in the negative sense):

    a) the quality of agricultural research carried out (e.g. due to reduced flow of knowledge/material between potential research partners or research
    projects being abandoned because of insufficient "freedom to operate")
    b) the nature of research collaborations between the public and private sector (i.e. in the context that private sector research (stimulated by IPRs) is increasingly important and that public-private sector partnerships are more frequent)
    c) the nature of research collaborations between developing and developed countries (e.g. the traditional system of sharing research benefits between developed and developing countries is changed).

    3. Whether IPRs favour the interests of developed countries and the biotechnology industry over those of developing countries

    Some of the arguments considered here, which were occasionally quite political, included
    a) whether the very nature of the current IPRs system discriminated against (or, even, allowed the exploitation of) developing countries because it places a greater value on biotechnology outputs than on genetic resources used to create the biotechnology products
    b) who owned patents in developing countries and the implications of developing countries harmonising or introducing national IPRs legislation.

    In the conference, participants also discussed how these negative impacts or consequences could be avoided or alleviated. They seemed to have two different approaches. The first was to call for a reassessment of the current IPRs system and to propose alternative systems that, for example, were weighted more towards developing countries interests or that were compatible with farmers' rights or did not allow legal ownership of life forms. The second was to accept the current system (even though they might consider it to be unjust) and, instead, to seek strategies to minimise its negative impacts. These strategies included the pooling of IPRs held by the public sector into an IPRs portfolio to serve poor farmers; applying IPRs legislation in a way that minor or trivial inventions could not be patented, useful follow-on research could not be restricted and challenging of invalid patents would be easier; encouraging governments in developed countries to stimulate their universities, research institutes and private companies to share their biotechnology products and processes with developing countries free of charge and, finally, when appropriate, getting private companies to provide biotechnology products at a reasonable price to developing countries.

    Some other topics raised in the conference were the implications of the WTO agreement on Trade-Related Aspects of Intellectual Property Rights (the TRIPS Agreement); infringement and enforcement of IPRs legislation in developing countries; the consequences of a biotechnology product being developed using many patented biotechnologies; PVP versus patenting and, finally, patenting in the livestock sector.

    For those with access to the web, further information on what the participants said can be got by viewing the actual messages they posted ( http://www.fao.org/biotech/logs/c6logs.htm ) or by reading the Long Version of the Summary Document ( http://www.fao.org/biotech/logs/C6/summary.htm ).

Comments? biotech-admin@fao.org
© FAO, 2001